Table 2:
Patient Age Category | Protocol | CTDIvol (mGy) |
Noise (HU) |
||||
---|---|---|---|---|---|---|---|
Original | Dose-Reduced | Difference | Original | Dose-Reduced | Difference | ||
0–23 mo | Brain | 15.0 ± 0.7 | 8.0 ± 0.4 | −47% | 4.4 ± 1.0 | 4.2 ± 0.7 | −3% |
2–5 yr | Brain | 24.1 ± 0.9 | 14.6 ± 0.6 | −39% | 4.2 ± 0.7 | 4.1 ± 0.7 | −3% |
6–10 yr | Brain | 26.3 ± 1.3 | 15.9 ± 0.4 | −40% | 4.1 ± 0.5 | 4.2 ± 0.6 | 4% |
11–18 yr | Brain | 29.1 ± 0.9 | 17.0 ± 0.5 | −42% | 4.4 ± 0.6 | 4.5 ± 0.6 | 3% |
≥ 19 yr | Brain | 36.6 ± 0.8 | 18.9 ± 0.5 | −48% | 4.3 ± 0.6 | 4.4 ± 0.4 | 3% |
0–18 yr | Maxilla | 19.4 ± 0.0 | 11.5 ± 0.1 | −41% | 11.2 ± 2.8 | 11.6 ± 1.6 | 3% |
≥19 yr | Maxilla | 22.8 ± 0.0 | 18.7 ± 0.2 | −18% | 9.6 ± 1.4 | 9.2 ± 1.7 | −3% |
0–18 yr | Orbits | 26.9 ± 8.0 | 15.8 ± 0.5 | −41% | 7.5 ± 1.2 | 7.2 ± 0.1 | −4% |
0–18 yr | Sinus | 13.1 ± 0.0 | 7.2 ± 0.3 | −45% | 8.5 ± 1.2 | 8.9 ± 1.1 | 5% |
≥19 yr | Sinus | 22.8 ± 0.0 | 13.7 ± 0.1 | −40% | 8.3 ± 0.9 | 8.2 ± 0.6 | −1% |
2–18 yr | Temporal | 40.7 ± 0.0 | 22.8 ± 0.0 | −44% | 9.3 ± 1.4 | 9.2 ± 1.2 | −2% |
≥19 yra | Temporal | 49.9 ± 0.0 | 29.7 ± 0.0 | −40% | 9.3 ± 1.0 |
No dose-reduced patient examinations were available for comparison. Dose-reduced CTDIvol value is calculated on the basis of scan parameters. Dose difference is a theoretic calculation.